HAE
Haemonetics Corp
Price:  
83.34 
USD
Volume:  
418,057.00
United States | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HAE WACC - Weighted Average Cost of Capital

The WACC of Haemonetics Corp (HAE) is 9.3%.

The Cost of Equity of Haemonetics Corp (HAE) is 10.45%.
The Cost of Debt of Haemonetics Corp (HAE) is 4.30%.

Range Selected
Cost of equity 8.90% - 12.00% 10.45%
Tax rate 15.90% - 20.10% 18.00%
Cost of debt 4.00% - 4.60% 4.30%
WACC 8.0% - 10.6% 9.3%
WACC

HAE WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.1 1.27
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.90% 12.00%
Tax rate 15.90% 20.10%
Debt/Equity ratio 0.2 0.2
Cost of debt 4.00% 4.60%
After-tax WACC 8.0% 10.6%
Selected WACC 9.3%